OMNI BIO PHARMACEUTICAL, INC. 4

4 · OMNI BIO PHARMACEUTICAL, INC. · Filed Apr 9, 2015

Form 4

Period: 2010-06-15

10% Owner

Transactions

Other
Warrant
2010-06-15+1,450,000→ 7,450,000 total
Exercise: $0.25From: 2009-03-31Exp: 2014-03-31→ Common Stock (1,450,000 underlying)
Other
Warrant
2010-06-15−2,900,000→ 7,450,000 total
Exercise: $0.50From: 2009-03-31Exp: 2014-03-31→ Common Stock (2,900,000 underlying)
Other
Warrant
2010-06-15−1,450,000→ 7,450,000 total
Exercise: $1.00From: 2009-03-31Exp: 2014-03-31→ Common Stock (1,450,000 underlying)
Other
Warrant
2013-07-30−2,900,000→ 7,450,000 total
Exercise: $0.25From: 2009-03-31Exp: 2014-03-31→ Common Stock (2,900,000 underlying)
Other
Warrant
2013-07-30−1,450,000→ 7,450,000 total
Exercise: $0.25From: 2009-03-31Exp: 2014-03-31→ Common Stock (1,450,000 underlying)
Other
Warrant
2013-07-30+2,900,000→ 7,450,000 total
Exercise: $0.25From: 2009-03-31Exp: 2017-03-31→ Common Stock (2,900,000 underlying)
Other
Warrant
2010-06-15+2,900,000→ 7,450,000 total
Exercise: $0.25From: 2009-03-31Exp: 2014-03-31→ Common Stock (2,900,000 underlying)
Other
Warrant
2013-07-30+1,450,000→ 7,450,000 total
Exercise: $1.00From: 2009-03-31Exp: 2017-03-31→ Common Stock (1,450,000 underlying)
Expiration
Warrant
2013-12-31−100,000→ 7,350,000 total
Exercise: $0.50From: 2009-03-31Exp: 2013-12-31→ Common Stock (100,000 underlying)

Footnotes (3)

[F1]This Warrant amends and restates in its entirety a previously reported Warrant for the same number of shares for the purpose of removing a restriction on exercise based on aggregate beneficial ownership.
[F2]This Warrant amends and restates in its entirety a previous Warrant for the same number of shares for the purpose of extending the contractual period to March 31, 2017.
[F3]Warrant Expired 12/31/2013.

Documents

1 file